PT-141 (Bremelanotide): What the Clinical Research Shows
The only FDA-approved peptide for sexual desire. We break down the clinical trials behind PT-141, how it works through melanocortin receptors in the brain, and what the data says about…
Research articles, peptide comparisons, clinical trial analysis, and the latest peptide science.
In-depth articles covering clinical research, peptide comparisons, sourcing guides, and the latest findings from peer-reviewed studies. Written for researchers and anyone tracking the evidence.
The only FDA-approved peptide for sexual desire. We break down the clinical trials behind PT-141, how it works through melanocortin receptors in the brain, and what the data says about…
Some peptides work better together than alone. We look at the research behind popular combinations, the science of synergy, and what to watch out for when stacking compounds.
The only FDA-approved GHRH analog specifically shown to reduce visceral belly fat. We cover the clinical trial evidence, how it works differently from other GH peptides, and its safety record.
Five growth hormone compounds, each with a different mechanism. We compare CJC-1295, Ipamorelin, GHRP-6, Tesamorelin, and MK-677 side by side on potency, side effects, and research status.
From telomere extension to skin repair, multiple peptides are being studied for anti-aging effects. We sort through the evidence and separate the promising leads from the hype.
A naturally occurring peptide that binds copper and shows up in wound healing, collagen production, and even hair growth research. We cover what makes GHK-Cu one of the most studied…
Scientists isolated the fat-burning segment of growth hormone and turned it into its own compound. We look at what the clinical and preclinical data actually shows about AOD-9604 for fat…
MK-677 is not a peptide but it acts like one, boosting growth hormone through the ghrelin receptor. We cover how it works, what the research shows for body composition, and…
Both are recovery peptides, but they work through completely different mechanisms. We compare TB-500 and BPC-157 on healing speed, tissue types, and what the animal studies show.
The STEP trial program put semaglutide through rigorous testing across different patient groups. Here is a breakdown of the weight loss results, side effects, and what happened after people stopped…
Two popular growth hormone peptides with very different release patterns. We compare how they stimulate GH, their half-lives, and what researchers have learned about using them.
BPC-157 is one of the most studied recovery peptides in animal research. We cover what scientists have found about gut healing, tendon repair, and tissue protection.
Three receptors versus two. We compare the mechanisms, trial results, and potential advantages of retatrutide over tirzepatide based on the data available so far.
A new peptide that hits three receptors instead of two. Early trial data suggests it could produce even more weight loss than tirzepatide. We look at what the Phase 2…
Tirzepatide works on two gut hormone receptors at once, and that dual action is why it outperforms single-target drugs. We walk through the biology of how it works.
The SURPASS trials tested tirzepatide across thousands of diabetes patients. Here is what the data actually showed for blood sugar control, weight loss, and how it stacked up against insulin.
The two biggest weight loss drugs go head to head. We break down the clinical trial numbers, side effect profiles, and mechanisms to show where each one actually wins.
Join our newsletter for weekly peptide research updates, new study summaries, and exclusive content delivered to your inbox.